A new molecular scissors act like a GPS to improve genome editing
Researchers from the University of Copenhagen (Denmark), led by the Spanish researcher Guillermo Montoya, have discovered how Cpf1, a new molecular scissors unzip and cleave DNA. This member of the CRISPR-Cas family displays a high accuracy, capable of acting like a GPS in order to identify its destination within the intricate map of the genome. The high precision of Cpf1 will improve the use of this type of technology in repairing genetic damage and in other medical and biotechnological applications.
A scientific team from in the Novo Nordisk Foundation Center for Protein Research (NNF-CPR), at the University of Copenhagen, has succeeded in visualizing and describing how a new system for genome editing, known as Cpf1, works. This protein belongs to the Cas family and enables the cleavage of double stranded DNA, thus allowing the initiation of the genome modification process. The results of the study have been published in the journal Nature.
Guillermo Montoya, a researcher in the fields of biochemistry and molecular biology who led the study, explains to SINC that the new molecular scissors “will enable us to more safely modify and edit the instructions written in the genome, due to the utmost precision of the target DNA sequence recognition”.
The new molecular scissors achieve complementary ends instead of blunt, as happens with Cas9, which facilitates the insertion of a DNA sequence
The CRISPR Cas9 system for cutting and paste genome sequences is already being used to modify animal and plant genomes. Also to treat illnesses, such as cancer and retinal diseases, in humans and its applications are growing very fast.
X-Ray Crystallography Technique
Researchers across the world are trying to perfect this genome editing technique with the aim of making it yet more precise and efficient. To achieve this, they have also focused on other proteins that specifically cut DNA, such as Cpf1, whose manipulation can direct them to specific locations in the genome. Montoya’s team has achieved this using an X-ray Crystallography to decipher the molecular mechanisms controlling this process.
“We radiated the crystals of the Cpf1 protein using X-rays to be able to observe its structure at atomic resolution, enabling us to see all its components,” points out the co-author of this study. “X-ray diffraction is one of the main biophysical techniques used to elucidate biomolecular structures,” he continues.
In his opinion, “the main advantage of Cpf1 lies in its high specificity and the cleaving mode of the DNA, since it is possible to create staggered ends with the new molecular scissors, instead of blunt-ended breaks as is the case with Cas9, which facilitates the insertion of a DNA sequence.”
“The high precision of this protein recognising the DNA sequence on which it is going to act functions like a GPS, directing the Cpf1 system within the intricate map of the genome to identify its destination. In comparison with other proteins used for this purpose, it is also very versatile and easy to be reprogrammed,” Montoya adds.
The high precision DNA sequence recognition functions as a GPS that directs the tool within the intricate map of the genome
Genetic diseases and tumours
These properties make this system “particularly suitable for its use in the treatment of genetic diseases and tumours,” he affirms.
The team has previously worked with the French biotechnology company Celletics on the use of meganucleases –other proteins that can be redesigned to cut the genome in a specific location– to treat certain types of leukemia.
The new technology “can also be used to modify microorganisms, with the aim of synthesising the metabolites required in the production of drugs and biofuels,” adds Montoya.
This researcher, from Getxo (Biscay, Spain), says that there are many companies interested in this new technology. They are mostly from the biotechnology sector in the field of microorganism manipulation, but cannot be named due to confidentiality agreements.
The Latest on: Genome editing
- CRISPR Screens Identify New Glioblastoma Targets and Resistance Genes on April 17, 2019 at 7:00 am
The approach used genome editing to effectively reverse engineer patient-derived, tumor-propagating glioblastoma stem cells (GSCs) gene by gene, and identify genes that are essential for tumor growth. ... […]
- Stanford clears its researchers in CRISPR-baby scandal on April 17, 2019 at 6:57 am
The CRISPR baby scandal has highlighted the shortcomings of existing guidelines. International medical leaders are planning a commission to guide genome editing, and there are calls for an ... […]
- Stanford clears three faculty members of ‘CRISPR babies’ involvement on April 17, 2019 at 6:14 am
A review by a faculty member and an outside investigator concluded that they “were not participants in [He Jiankui’s] research regarding genome editing of human embryos for intended implantation and ... […]
- Transcript: Jamie Metzl talks with Michael Morell on "Intelligence Matters" on April 17, 2019 at 4:00 am
... sequencing is allowing us to unlock the secrets of the genome in ways that would have been absolutely impossible 40 years ago. And then on top of that, there is precision gene editing, that allows ... […]
- Author Jamie Metzl says the "genetic revolution" could threaten national security on April 17, 2019 at 3:58 am
And that's going to have huge implications," he said. Metzl, who in 2019 was appointed to an advisory committee charged with developing global standards for human genome editing at the World Health ... […]
- IDT partners with iGEM to support young researchers and promote scientific progress on April 17, 2019 at 3:46 am
In order to make DNA synthesis accessible to all, the company will also again provide every registered team with up to 20KB of its market leading gBlocks ® Gene Fragments and Alt-R ® CRISPR Genome ... […]
- Genome Editing Market Business Opportunities, Application Analysis, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 – 2025 on April 17, 2019 at 1:42 am
The genome editing market was valued at US$ 3,210.1 in 2017 and is expected to reach US$ 10,691.0 Mn in 2025. The market is estimated to grow with a CAGR of 17.0% from 2017-2025. The report includes ... […]
- European Trends: Genome Editing Market to grow at a CAGR of 16.7% by 2025 - Regional Analysis and Forecasts on April 17, 2019 at 1:02 am
European Court of Justice Ruling on Genome Editing: Recently, under the EU regulation on genetically modified organisms the judgment is passed through the European Court of Justice that gene ... […]
- CasX: a new and small CRISPR gene-editing protein on April 16, 2019 at 1:15 pm
demonstrate the DNA cleavage characteristics of CasX (a newly identified dual-RNA-guided DNA targeting nuclease) and establish its capacity for genome editing in Escherichia coli and human cells. ... […]
- Human Gene Editing is Controversial. Shoukhrat Mitalipov Isn't Deterred on April 15, 2019 at 9:58 am
Chinese researcher He Jiankui’s announcement last November came on the eve of the International Summit on Human Genome Editing in Hong Kong. He was scheduled to give a talk on his work shortly after ... […]
via Google News and Bing News